Chios Mastic Gum: Chemical Profile and Pharmacological Properties in Inflammatory Bowel Disease: From the Past to the Future.

Roberta Ottria, Ornella Xynomilakis, Silvana Casati, Ezio Abbiati, Giovanni Maconi, Pierangela Ciuffreda

Journal: International journal of molecular sciences 2023;24(15):0

PMID: 37569412

Abstract

Chios mastic gum, the product of the tree var. , has been used for more than 2500 years in traditional Greek medicine for treating several diseases, thanks to the anti-inflammatory and antioxidant properties of its components. Despite the long-time use of mastic in gastroenterology and in particular in chronic-inflammation-associated diseases, to date, the literature lacks reviews regarding this topic. The aim of the present work is to summarize available data on the effects of on inflammatory bowel disease. A comprehensive review of this topic could drive researchers to conduct future studies aimed at deeply investigating effects and hypothesizing a mechanism of action. The present review, indeed, schematizes the possible bioactive components of mastic gum. Particular care is given to var. medicaments' and supplements' chemical compositions and their pharmacological action in inflammatory bowel disease.

Address: Dipartimento di Scienze Biomediche e Cliniche, Università degli Studi di Milano, 20157 Milan, Italy.; Phytoitalia S.r.l., Via Gran Sasso, 37, Corbetta, 20011 Milan, Italy.; Gastroenterology Unit, Luigi Sacco University Hospital, 20157 Milan, Italy.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.